Clinical Trial Update: Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial of autologous ex vivo conjunctival epithelial cell expansion for ocular surface transplantation has completed, evaluating treatment for pterygium …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemical Eye Injury
• Ocular Surface Disease
• Pterygium
• Stevens-johnson Syndrome

Drugs mentioned

• Autologous ex vivo conjunctival epithelial cell expansion for ocular surface transplantation

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Pterygium, Ocular Surface Disease | Phase 3 | Status: COMPLETED